Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Almond Tree Capital Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 4
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Key employees Soon

Areas of investment

  • Health Diagnostics
  • Medical Device
  • Health Care
  • Medical
  • Small and Medium Businesses

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Almond Tree Capital Fund:
Typical Co-investors
Almond Tree Capital Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Almond Tree Capital Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
212 Ventures New York, New York, United States
Active Capital Trust England, London, United Kingdom
Avista Capital Partners New York, New York, United States
Beta Boom California, Los Angeles, United States
Camelot Financial Capital Management -
Huge Thing Mazowieckie, Poland, Warszawa
JBC China, Shanghai
Miyamoto International -
Neon Adventures England, London, United Kingdom
Oriella PR Network England, London, United Kingdom
Palmieri Family Trust -
PHOENIX group Baden-Wurttemberg, Germany, Mannheim
Psion Teklogix Canada, Mississauga, Ontario
Sculley Brothers New York, New York, United States
Shenzhen Haichen Touzi Hehou Qiye China, Guangdong, Shenzhen
The Orangepage Japan, Tokyo
Unicore Technology Company -
Virginia Research Investment Committee Richmond, United States, Virginia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

TriVirum

Health Care
Health Diagnostics
Medical
Medical Device
$1M24 Dec 2020 California, United States

Promaxo

Health Care
Health Diagnostics
Medical Device
Therapeutics
$2M11 Apr 2018 Oakland, California, United States

PhotoniCare

Diagnostic Equipment
Health Care
Health Diagnostics
Medical Device
$2M06 Mar 2018 Champaign, Illinois, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Almond Tree Capital Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 1M
Peak activity year 2020
Lead investments 0
Follow on index 0.43
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

TriVirum

Health Care
Health Diagnostics
Medical
Medical Device
$1M24 Dec 2020 California, United States

Promaxo

Health Care
Health Diagnostics
Medical Device
Therapeutics
$2M11 Apr 2018 Oakland, California, United States

PhotoniCare

Diagnostic Equipment
Health Care
Health Diagnostics
Medical Device
$2M06 Mar 2018 Champaign, Illinois, United States
Crunchbase icon

Content report

The following text will be sent to our editors: